Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-08
2011-03-08
Chandrakumar, Nizal S (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07902379
ABSTRACT:
The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which A, R3, R4, R5R6and R7are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivatives can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
REFERENCES:
patent: 5594023 (1997-01-01), Wagnon et al.
patent: 6090818 (2000-07-01), Foulon et al.
patent: 6596732 (2003-07-01), Serradeil-Le Gal et al.
patent: 6624164 (2003-09-01), Schoentjes et al.
patent: 6864277 (2005-03-01), Roux et al.
patent: 7119086 (2006-10-01), Di Malta et al.
patent: 2003/0114683 (2003-06-01), Roux et al.
patent: 2005/0070718 (2005-03-01), Lubisch et al.
patent: 2007/0021607 (2007-01-01), Lubisch et al.
patent: 2008/0318923 (2008-12-01), Sekiguchi et al.
patent: 2009/0005397 (2009-01-01), Lubisch
patent: 2009/0163492 (2009-06-01), Oost
patent: 2009/0215790 (2009-08-01), Lubisch
patent: 2107348 (1992-01-01), None
patent: 93/15051 (1993-08-01), None
patent: WO93/15051 (1993-08-01), None
patent: 95/18105 (1995-07-01), None
patent: WO 95/18105 (1995-07-01), None
patent: 98/25901 (1998-06-01), None
patent: WO 98/25901 (1998-06-01), None
patent: 01/55130 (2001-08-01), None
patent: 01/55134 (2001-08-01), None
patent: WO 01/55130 (2001-08-01), None
patent: WO 01/55134 (2001-08-01), None
patent: 01/64668 (2001-09-01), None
patent: WO 01/64668 (2001-09-01), None
patent: 2001/98295 (2001-12-01), None
patent: WO 01/98295 (2001-12-01), None
patent: WO /01/98295 (2001-12-01), None
patent: 03/08407 (2003-01-01), None
patent: WO 03/008407 (2003-01-01), None
patent: 2005/030755 (2005-04-01), None
patent: 2006/005609 (2006-01-01), None
patent: 2006/080574 (2006-08-01), None
patent: 2006/100081 (2006-09-01), None
patent: 2006/100082 (2006-09-01), None
Barberis, et al., Structural bases of vasopression/osytocin receptor function, > Endocrinology, 1998, 223-229, vol. 156, France.
Hulme, et al., Quatermary Substituted PDE4 Inhibitors 1: The synthesis and in Vitro Evaluation of a Novel Series of Oxindoles, Bioorg. & Med. Chem. Lett, 1998, 175-178, vol. 8, United Kingdom.
Wersinger, et al., Vasopressin V1b receptor knockout reduces aggressive behavior in male mice, Molecular Psychiatry, 2002, 975-984, vol. 7, United Kingdom.
Griebel, et al. Anxiolytic- and antidepressant-like effects of the nonpeptid vassopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders, PNAS, 2002, 6370-6375, vol. 99, France.
Serradeil-Le Gal, et al., J. Pharm. Exp. Ther., 2002, 1122-1130, vol. 300, France.
Barberis et al., “Structural bases of vasopressin/osytocin receptor function,” J. Endocrinology, 1998, 223-229, vol. 156, France.
Hulme et al., “Quasternary Substituted PDE4 Inhibitors 1: The Synthesis and in Bitro Evaluation of a Novel Series of Oxindoles,” Bioorg. & Med. Chem Lett, 1998, 175-178, vol. 8, United Kingdom.
Wersinger et al., “Vasopressin V 1b Receptor Knockout Reduces Aggressive Behavior in male mice,” Molecular Psychiatry, 2002, 975-984, vol. 7, United Kingdom.
Griebel et al., “Anxiolytic-and Antidepressant-like Effects of the Non-peptide Vassopressin V 1b Receptor Antagonist, SSR 149415, Suggest as Innovative Approach for the Treatment of Stress-related Disorders,” PNAS, 2002, 6370-6375, vol. 99, France.
Serradeil-Le Gal et al., J. Pharm. Exp. Ther., 2002, 1122-1130, vol. 300, France.
Thibonnier, M., Exp. Opin. Invest. Drugs, 1998, vol. 7, No. 5, pp. 729-740.
Office Action filed for U.S. Appl. No. 11/440,569 and mailed Aug. 4, 2009.
Office Action filed for U.S. Appl. No. 11/440,569 and mailed Dec. 9, 2008.
Geneste Hervé
Hornberger Wilfried
Lubisch Wilfried
Oost Thorsten K.
Sauer Daryl Richard
Abbott & GmbH & Co. KG
Chandrakumar Nizal S
Mueller Lisa V.
Polsinelli Shughart PC
LandOfFree
Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2668493